本次交易的标的公司为宁波甬强科技有限公司。本次交易事项尚处于筹划阶段，初步确定的交易对方为 包括甬强科技实际控制人JIANGQIHE及其一致行动人QIANGYUAN、宁波源路载科技合伙企业(有限合 伙)在内的标的公司全部或部分股东。本次交易对方的范围尚未最终确定，最终确定的交易对方以后续 公告披露的信息为准。 中国经济网北京1月4日讯延江股份（300658）(300658.SZ)今日披露关于筹划重大资产重组的停牌公告 称，延江股份正在筹划发行股份等方式购买资产事项，同时拟募集配套资金，预计本次交易可能构成 《上市公司重大资产重组管理办法》规定的重大资产重组。 因有关事项尚存不确定性，为了维护投资者利益，避免对公司证券交易造成重大影响，根据深圳证券交 易所的相关规定，经公司申请，公司证券(证券品种：A股股票，证券简称：延江股份，证券代码： 300658)自2026年1月5日开市时起开始停牌。公司预计在不超过10个交易日的时间内披露本次交易方 案，即在2026年1月19日前按照《公开发行证券的公司信息披露内容与格式准则第26号——上市公司重 大资产重组》的要求披露相关信息。 若公司未能在上述期限内召开董事会审议并 ...

延江股份表示，公司预计在不超过10个交易日的时间内披露本次交易方案，即在1月19日前披露相关信 息。若公司未能在上述期限内召开董事会审议并披露交易方案，公司证券最晚将于1月19日开市起复牌 并终止筹划相关事项。 公告显示，预计本次交易可能构成《上市公司重大资产重组管理办法》规定的重大资产重组。 据了解，甬强科技成立于2019年12月，主要研发生产IC载板、高端显示基板、高速高频载板等，自成立 以来已获得多家产业资本及知名基金参与的三轮总额达2.1亿元市场化投资，估值超10亿元。 北京商报讯（记者 马换换 王蔓蕾）1月4日，延江股份（300658）披露公告称，公司拟以发行股份及支 付现金的方式购买宁波甬强科技有限公司（以下简称"甬强科技"）控制权，并募集配套资金。公司证券 自1月5日起开始停牌。 ...

南财智讯1月4日电，延江股份公告，公司正在筹划以发行股份及支付现金的方式购买宁波甬强科技有限 公司控制权，并募集配套资金，预计构成重大资产重组。因有关事项尚存不确定性，公司证券自2026年 1月5日开市时起停牌，预计在不超过10个交易日内披露交易方案，即最晚于2026年1月19日复牌。若未 能按期披露，公司证券将于2026年1月19日开市起复牌并终止筹划相关事项。本次交易尚处于筹划阶 段，尚未签署正式协议，具体方案存在不确定性，敬请投资者注意投资风险。 ...

厦门延江新材料股份有限公司 关于筹划重大资产重组的停牌公告 证券代码：300658 证券简称：延江股份 公告编号：2026-001 厦门延江新材料股份有限公司 关于筹划重大资产重组的停牌公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、停牌事由和工作安排 厦门延江新材料股份有限公司（以下简称"公司"或"延江股份"）正在筹 划发行股份等方式购买资产事项，同时拟募集配套资金，预计本次交易可能构成 《上市公司重大资产重组管理办法》规定的重大资产重组。因有关事项尚存不确 定性，为了维护投资者利益，避免对公司证券交易造成重大影响，根据深圳证券 交易所的相关规定，经公司申请，公司证券（证券品种：A 股股票，证券简称： 延江股份，证券代码：300658）自 2026 年 1 月 5 日开市时起开始停牌。 公司预计在不超过 10 个交易日的时间内披露本次交易方案，即在 2026 年 1 月 19 日前按照《公开发行证券的公司信息披露内容与格式准则第 26 号——上市 公司重大资产重组》的要求披露相关信息。 若公司未能在上述期限内召开董事会审议并披露交易方案，公司证券最 ...

Market Overview - The personal care products sector increased by 0.23% on December 31, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3968.84, up 0.09%, while the Shenzhen Component Index closed at 13525.02, down 0.58% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 14.82, up 11.68% with a trading volume of 314,600 shares and a transaction value of 445 million yuan [1] - Other notable stocks include: - Dengkang Oral (001328) at 39.48, up 1.23% [1] - Zhongshun Jierou (002511) at 8.56, up 1.06% [1] - Beijia Clean (603059) at 30.08, up 0.37% [1] - Reliable Co., Ltd. (301009) at 12.68, up 0.32% [1] - Runben Co., Ltd. (603193) at 24.23, up 0.12% [1] - Haoyue Nursing (605009) at 30.90, up 0.03% [1] - Ziya Co., Ltd. (003006) at 21.84, down 0.46% [1] - Wanjian Medical (300888) at 37.84, down 0.58% [1] - Liangmian Needle (600249) at 5.75, down 1.71% [1] Capital Flow - The personal care products sector experienced a net outflow of 31.67 million yuan from institutional investors, while retail investors saw a net inflow of 26.33 million yuan [2] - The capital flow for individual stocks shows: - Yanjiang Co., Ltd. had a net inflow of 18.80 million yuan from institutional investors [3] - Dengkang Oral had a net inflow of 0.90 million yuan from retail investors [3] - Reliable Co., Ltd. had a net outflow of 3.37 million yuan from institutional investors [3] - Zhongshun Jierou had a net outflow of 7.21 million yuan from institutional investors [3] - Yiyi Co., Ltd. had a net outflow of 9.23 million yuan from institutional investors [3]

Market Overview - The personal care products sector experienced a slight decline of 0.1% on December 30, with Liangmian Needle leading the drop [1] - The Shanghai Composite Index closed at 3965.12, down 0.0%, while the Shenzhen Component Index closed at 13604.07, up 0.49% [1] Stock Performance - Notable stock performances in the personal care sector included: - Zhiya Co., Ltd. (003006) rose by 3.69% to close at 21.94, with a trading volume of 80,900 shares and a turnover of 178 million yuan [1] - Jieya Co., Ltd. (301108) increased by 1.04% to 33.86, with a trading volume of 10,700 shares and a turnover of 36.07 million yuan [1] - Liangmian Needle (600249) fell by 1.52% to 5.85, with a trading volume of 99,500 shares and a turnover of 58.49 million yuan [2] Capital Flow - The personal care products sector saw a net inflow of 23.84 million yuan from institutional investors, while retail investors experienced a net outflow of 48.31 million yuan [2] - The capital flow for individual stocks showed: - Yanjiang Co., Ltd. (300658) had a net inflow of 33.52 million yuan from institutional investors [3] - Liangmian Needle (600249) had a net outflow of 3.21 million yuan from institutional investors [3] Summary of Individual Stocks - The following stocks had significant capital movements: - Zhiya Co., Ltd. (003006) had a net inflow of 17.45 million yuan from institutional investors [3] - Jieya Co., Ltd. (301108) saw a net outflow of 0.87 million yuan from institutional investors [3] - Stable Medical (300888) had a net outflow of 3.61 million yuan from institutional investors [3]

Market Overview - The personal care products sector increased by 0.49% compared to the previous trading day, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Stock Performance - Dengkang Oral (001328) closed at 38.95, up 2.04% with a trading volume of 19,000 shares and a transaction value of 73.72 million yuan [1] - Other notable performers include: - Yanjing Co. (300658) at 13.18, up 1.62% [1] - Stable Medical (300888) at 38.64, up 1.47% with a transaction value of 252 million yuan [1] - Zhongshun Jiesang (002511) at 8.45, up 1.32% with a transaction value of 191 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.12 million yuan from institutional investors and 8.75 million yuan from retail investors, while retail investors saw a net inflow of 17.87 million yuan [2] - The capital flow for individual stocks shows: - Stable Medical had a net inflow of 18.89 million yuan from institutional investors [3] - Dengkang Oral saw a net outflow of 3.00 million yuan from institutional investors [3] - Yanjing Co. had a net inflow of 1.24 million yuan from institutional investors [3] Summary of Individual Stocks - The following stocks had significant capital movements: - Dengkang Oral: Institutional net outflow of 3.00 million yuan, retail net inflow of 0.80 million yuan [3] - Stable Medical: Institutional net inflow of 18.89 million yuan, retail net outflow of 20.84 million yuan [3] - Zhongshun Jiesang: Institutional net outflow of 3.24 million yuan, retail net inflow of 4.70 million yuan [3]

Market Overview - The personal care products sector increased by 0.94% on December 25, with Zhongshun Jierou leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] Stock Performance - Zhongshun Jierou (002511) closed at 8.22, up 4.18% with a trading volume of 308,300 shares and a transaction value of 251 million [1] - Other notable stocks include: - Jieya Co. (301108) at 33.92, up 1.83% [1] - Runben Co. (603193) at 24.72, up 1.39% [1] - Haoyue Nursing (600509) at 31.99, up 1.07% [1] - Baia Co. (003006) at 21.15, up 1.05% [1] Capital Flow - The personal care products sector experienced a net outflow of 34.64 million from institutional investors and 29.15 million from retail investors, while retail investors saw a net inflow of 63.79 million [2] - The capital flow for individual stocks shows: - Zhongshun Jierou had a net inflow of 2.63 million from institutional investors [3] - Two Mian Zhen (600249) had a net inflow of 201.73 thousand from institutional investors [3] - Jieya Co. (301108) had a net outflow of 64.45 thousand from institutional investors [3]

证券之星消息，12月24日个护用品板块较上一交易日上涨0.5%，延江股份领涨。当日上证指数报收于 3940.95，上涨0.53%。深证成指报收于13486.42，上涨0.88%。个护用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300658 | 延江股份 | 13.39 | 8.07% | 27.43万 | 3.61亿 | | 301108 | 洁雅股份 | 33.31 | 1.99% | 9945.11 | 3288.27万 | | 001206 | 依依股份 | 31.14 | 1.53% | 3.07万 | 9459.40万 | | 605009 | 豪悦护理 | 31.65 | 1.05% | 1.50万 | 4741.32万 | | 600249 | 两面针 | 6.12 | 0.66% | 9.25万 | 5632.98万 | | 301009 | 可靠股份 | 12.91 | 0.47% | 2.80万 | 3607.21万 | | 002511 | 中 ...

Investment Rating - The industry investment rating is "Recommended," indicating a positive outlook for the industry fundamentals, with expectations that the industry index will outperform the benchmark index [25]. Core Insights - The restructuring of the overseas supply chain presents opportunities for domestic non-woven fabric companies, as they can benefit from the pressures faced by major brands like Kimberly-Clark and Procter & Gamble, which are experiencing declining revenues in their core categories [4][5]. - The performance of leading non-woven fabric companies such as Yanjiang, Jieya, and Nuobang shows significant revenue growth, with year-on-year increases of 17%, 107%, and 23% respectively in Q3 2025, indicating a recovery trend driven by improved order structures and increased overseas orders [11][16]. - The shift in the global disposable hygiene products industry from a focus on market share to efficiency across the supply chain is evident, as brands are now prioritizing cost efficiency and localized responses to maintain profitability in a challenging market environment [5][10]. Summary by Sections Section 1: Pressure on Overseas Giants and Supply Chain Restructuring - Major brands like Kimberly-Clark are facing revenue declines in their baby and feminine care segments, with Q3 2025 revenues of approximately $5.09 billion and $1.29 billion, down 4.1% and 2.4% year-on-year respectively [5]. - The competitive landscape is shifting, with brands needing to enhance supply chain efficiency and local responsiveness to sustain profits amid slowing growth in mature markets [9][10]. Section 2: Recovery of Non-Woven Fabric Companies - Leading non-woven fabric companies are showing a clear recovery, with significant revenue growth in Q3 2025, indicating a positive trend following a period of inventory destocking and intensified competition [11][15]. - Profitability is also improving, with Yanjiang, Jieya, and Nuobang reporting net profit growth of 209%, 336%, and 21% respectively in Q3 2025, driven by enhanced product structures and increased overseas orders [16][20]. Section 3: Overseas Capacity Layout and Localization of Supply - Companies like Yanjiang are establishing production capacities in regions like Egypt and the U.S. to enhance delivery efficiency and better serve local markets, with plans to achieve significant sales targets by 2027 [21][22]. - The overseas production strategy is aligned with the supply chain adjustments of downstream brands, indicating a broader trend towards localized manufacturing to improve competitiveness and responsiveness to market demands [22].